Quantification of subtype purity in Luminal A breast cancer predicts clinical characteristics and survival. Kumar N, Gann PH, McGregor SM, Sethi A, et al. Breast Cancer Res Treat 2023 May 20. doi: 10.1007/s10549-023-06961.

Read + Share

Amedeo Smart

Independent Medical Education

Kumar N, Gann PH, McGregor SM, Sethi A, et al. Quantification of subtype purity in Luminal A breast cancer predicts clinical characteristics and survival. Breast Cancer Res Treat 2023 May 20. doi: 10.1007/s10549-023-06961.
PMID: 37209182